CorEvitas, has expanded its partnership with Inovalon’s life sciences business unit specializing in data-driven healthcare analytics and strategic advisory services, to provide a holistic view of patients with rheumatoid arthritis or psoriasis.
In conjunction with CorEvitas’ clinical data on validated physician assessments and patient-reported outcomes, this collaboration focuses on rheumatoid arthritis and psoriasis and highlights one of many critical chronic condition-focused use cases of Inovalon’s MORE² Registry® dataset, which today provides the healthcare marketplace insight into tens millions of patients suffering from key chronic conditions. Read more.
